Factors contributing to the high CAGR are ease of consultation, increasing implementation of digital pathology and rising prevalence of cancer. Further, technological advancements, product launches, collaborations, partnerships and acquisitions are anticipated to fuel the overall market growth of global digital pathology market across the globe
Market Size – USD 540.9 Million in 2024, Market Growth – CAGR of 12.2%, Market Trends – Product Launches and Research for Advanced Tech Developments
Based on current analysis the global digital pathology market was valued at USD 540.9 Million in 2024 and is expected to reach USD 1,432.4 Million by 2028, at a CAGR of 12.2%. Digital pathology is an innovation predominantly committed to improve operational efficiency, minimization of laboratory expenses, enhanced productivity, improving treatment decisions and patient care. Interpretation of pathology information generated from a digitized glass slide is known as digital pathology. Virtual microscopy is a part of digital pathology which enables to practice converting glass slides into digital slides that can be viewed, managed, shared and analyzed on a computer monitor. Digital pathology is presently considered as one of the most promising areas of diagnostic medicine in order to achieve accurate, feasible and faster diagnosis, prognosis and prediction of cancer and other important diseases. Market drivers for digital pathology market are growing applications of digital pathology, ease of consultation, increasing implementation of digital pathology to boost lab efficiency, rising prevalence of cancer, and increasing interventions by governments and initiatives by key industry players.
Get a sample copy of the global Digital Pathology market report @ https://www.reportsanddata.com/sample-enquiry-form/1493
Increasing development of on-demand, digitally enabled, and seamlessly connected clinician-patient interactions to manage patient base is expected to drive pharma and healthcare market in the coming years. After the COVID-19 outbreak there has been a number of foundational shifts in the healthcare system. Some of the examples include increasing consumer involvement in health care decision-making, the rapid adoption of virtual health & other digital innovations, increasing focus on utilization of interoperable data & data analytics, and increased public-private collaborations in therapeutics and vaccine development. The increased public-private collaborations for vaccine development has arisen due to high pressure of regional governments. Health care providers, and other stakeholders have invested heavily to quickly pivot, adapt, and innovate therapeutics.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1493
Digital Pathology Market Segmentation:
Product (Revenue in USD Million; 2024–2028)
- scanners
- software
- communication systems
- slide management systems
- storage systems
Type (Revenue in USD Million; 2024–2028)
- Human pathology
- Veterinary pathology
Applications (Revenue in USD Million; 2024–2028)
- Teleconsultation
- Disease Diagnosis
- Drug Discovery and development
- Cancer cell detection
- Others
End Use (Revenue in USD Million; 2024–2028)
- Pathology labs
- Pharmaceutical & Biotechnology Companies
- Hospitals
- Academic & Research Institutes
Key Regional Markets Studied in the Report:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- The Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
To know more about the report @ https://www.reportsanddata.com/report-detail/digital-pathology-market
Key findings from the report
- There were an estimated 15.5 million cancer survivors in the United States. The number of cancer survivors is expected to increase to 20.3 million by 2028. Due to increase in the chances of survival, it is expected to increase the market revenue of digital pathology
- Biotech and pharma companies are predicted to showcase a stable growth during the forecast period. The growth is credited to enlarged use of digital pathology in drug development, oncology clinical trials, and preclinical GLP pathology. Cumulative occurrence of cancer and demand for better treatment options is further fueling the market
- Teleconsultation segment in applications of digital pathology market is estimated to account for the highest share of 45.8% in the market due to accessibility to patients in remote areas with specialist pathological consultation
- Asia-Pacific regional segment of the digital pathology market is expected to register itself as highest growing segment during the forecasted period, at a CAGR of 13.4%; owing it to the qualitative as well as quantitative market potential offered in developing nations such as China & India
- Owing to increasing adoption of digital pathology solution worldwide, the scanners segment is expected to dominate the digital pathology market with growing CAGR of 11.7%
- In 2024, an estimated 1,735,350 new cases of cancer were diagnosed in the United States and it is anticipated that approximately 609,640 people will die from the disease. Thus, it is likely to prosper the digital pathology market due to high prevalence of the target disease
- Roughly 38.4% of men and women are likely to be diagnosed with cancer at some point during their lifetimes. In 2017, it was estimated that around 15,270 children and adolescents ages 0 to 19 were diagnosed with cancer and 1,790 died of the disease
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1493
Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.
Read More Related Reports:-
Renal Cell Cancer Treatment Market Size
Browse More Reports:
Point of Care Glucose Testing Market Trends
Organs-on-Chips Market Forecast
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
